Trial record 1 of 1 for:    01508910
Previous Study | Return to List | Next Study

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina (RENEW)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Baxalta US Inc.
ClinicalTrials.gov Identifier:
NCT01508910
First received: January 10, 2012
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
No publications provided by Baxalta US Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):